The pharma blogs Diaries
January 21, 2025 In 21 CFR 211.ninety four it's stated that “Drug product or service containers and closures shall not be reactive, additive, or absorptive to change the safety, identification, energy, quality or purity of the drug over and above the official or established prerequisites.” Although the code tends to make this assertion, and if